Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABOS | AMGN | VRTX | REGN | BMY |
| Company | Acumen Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.31 | 277.69 | 402.95 | 900.00 | 44.36 |
| High | 3.35 | 278.52 | 404.07 | 943.77 | 44.42 |
| Low | 3.24 | 274.90 | 398.46 | 891.30 | 43.33 |
| Last | 3.26 | 276.20 | 400.98 | 940.58 | 43.91 |
| Change | +0.01 | -1.17 | -1.16 | +37.10 | -0.30 |
| % Change | +0.31% | -0.42% | -0.29% | +4.11% | -0.68% |
| Volume | 61,113 | 1,079,856 | 488,680 | 533,780 | 7,854,960 |
| 20-Day Average Volume | 223,677 | 2,169,697 | 975,171 | 481,292 | 13,891,645 |
| Previous Close | 3.25 | 277.37 | 402.14 | 903.48 | 44.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.42 | 270.03 | 398.82 | 909.13 | 47.84 |
| 20-Day Raw Stochastic | 19.38% | 74.43% | 59.67% | 82.88% | 7.94% |
| 20-Day Relative Strength | 40.78% | 50.41% | 47.95% | 54.01% | 28.14% |
| Weighted Alpha | -40.14 | +13.18 | +14.84 | +23.14 | -36.66 |
| Today's Opinion | 72% Sell | 24% Sell | 8% Buy | 48% Buy | 88% Sell |
| Previous Opinion | 72% Sell | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Last Month's Opinion | 16% Buy | 8% Sell | 40% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.89% since 04/25/24 | +2.06% since 04/25/24 | +1.16% since 04/25/24 | +5.21% since 04/25/24 | -1.58% since 04/25/24 |
| Low | 3.13 on 04/26/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.37 on 05/01/24 | 279.84 on 05/01/24 | 406.95 on 05/01/24 | 939.60 on 05/02/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | -14.24% since 04/02/24 | -0.46% since 04/02/24 | -1.74% since 04/02/24 | -1.85% since 04/02/24 | -16.58% since 04/02/24 |
| Low | 3.07 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 4.06 on 04/04/24 | 279.84 on 05/01/24 | 414.95 on 04/03/24 | 962.20 on 04/04/24 | 52.87 on 04/03/24 |
| 3-Month | |||||
| %Chg | +9.43% since 02/02/24 | -14.93% since 02/02/24 | -5.27% since 02/02/24 | -0.86% since 02/02/24 | -9.68% since 02/02/24 |
| Low | 2.95 on 02/05/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 5.09 on 03/04/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +65.83% since 11/02/23 | +3.13% since 11/02/23 | +6.84% since 11/02/23 | +14.44% since 11/02/23 | -13.95% since 11/02/23 |
| Low | 1.81 on 11/10/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 5.09 on 03/04/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 195,260 | 148,774,592 | 103,936,712 | 99,167,768 | 89,618,088 |
| Shares Outstanding, K | 60,080 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -52,370,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -16,500,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.19 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 03/26/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.69 | 29.23 | 23.70 | 41.85 |